1,600+ royalty-bearing deals | 537 underlying licensing agreements | 10+ years of comparable transactions | Tailored Executive Briefing available
Benchmark Royalty Rates Against Real-World Pharmaceutical and Biotechnology Licensing Deals
What is a realistic royalty rate for a pharmaceutical or biotechnology licensing deal - and what evidence can you use to support that rate in a negotiation?
Royalty Rates in Pharmaceutical and Biotechnology Licensing Deals 2015-2026 provides an evidence-based resource for answering these questions, drawing on more than 1,600 royalty-bearing licensing transactions.
Designed for business development, licensing, valuation, legal, strategy and executive teams, the report enables users to benchmark proposed royalty terms against real-world comparable transactions and evaluate royalties in the context of the wider deal economics, rights structure and development profile of the asset.
The objective is not simply to identify a royalty percentage; it is to understand whether that royalty is realistic, how it compares with relevant market precedents, and how it fits within the complete economics of the transaction.
Comparable Transactions: Find the Deals That Matter Most
A royalty rate is only useful as a benchmark if the underlying transaction is genuinely comparable.
The report helps users identify licensing deals that more closely match the asset, technology or transaction they are evaluating, rather than relying on broad industry averages or isolated headline royalty figures.
Comparable transactions can be assessed according to factors including:
- Development stage
- Therapeutic area
- Technology type
- Company
- Deal type
- Territorial scope
- Exclusivity
- Upfront payments
- Milestone structures
- Overall deal economics
This enables business development, licensing, valuation and strategy teams to build a more relevant set of transaction precedents and assess whether proposed royalty terms are realistic, defensible and consistent with market practice.
For teams preparing for a negotiation, valuation or internal deal review, this comparable-deal evidence provides a stronger basis for supporting assumptions, challenging proposed terms and identifying the range within which similar transactions have actually been agreed.
Why Generic AI Is Not a Substitute for This Intelligence
Generic AI tools can search and summarise publicly available information. They do not provide access to proprietary, analyst-curated royalty rate dataset or its structured body of comparable licensing transactions.
The report combines:
- More than 1,600 royalty-bearing pharmaceutical and biotechnology licensing deals
- 537 underlying licensing agreements
- Structured analysis by development stage, therapeutic area, technology, company and deal type
- Detailed financial terms including royalties, upfront payments, milestones and total deal value
- Analysis of exclusivity, territorial rights and transaction structure
- Analyst-curated comparable transaction intelligence built specifically for life sciences licensing and business development
An AI search may help locate an individual announcement or summarise a known transaction. This report provides the structured evidence base needed to identify genuinely comparable deals, benchmark royalty rates in context and examine the contractual terms behind hundreds of real licensing agreements.
The analyst provides the evidence, structure and expert interpretation needed to support a real licensing decision.
Reasons to Buy
- Benchmark royalty rates against more than 1,600 real pharmaceutical and biotechnology licensing deals to establish a stronger evidence base for valuation and negotiation
- Identify genuinely comparable transactions by development stage, therapeutic area, technology, company and deal structure rather than relying on broad industry averages
- Review 537 underlying licensing agreements to examine how royalty clauses and related commercial terms are structured in real-world transactions
- Assess whether proposed royalty terms are commercially realistic and defensible by comparing royalty rates, ranges, tiered structures and associated payment terms in similar deals
- Understand the complete economics behind the royalty rate, including how royalties interact with upfront payments, milestones, exclusivity and territorial rights
- Strengthen licensing negotiations, valuations and internal deal approvals with objective comparable-transaction evidence
- Qualifying purchasers may receive a complimentary tailored Executive Briefing, applying the report's evidence to their own asset, technology, platform or partnering priorities
Key Questions Answered
The report can help users answer commercially important questions including:
- What royalty rates have been agreed in genuinely comparable pharmaceutical and biotechnology licensing deals?
- What royalty range may be realistic and defensible for an asset at a particular development stage?
- How do royalty rates vary by therapeutic area, technology and stage of development?
- How do royalty rates interact with upfront payments, milestones, exclusivity and territorial rights?
- When are tiered, escalating or variable royalty structures used, and how are they structured?
- Which comparable transactions provide the strongest evidence for a valuation, negotiation position or internal deal approval?
What the Report Includes
The August 2026, 11th edition covers more than 1,600 royalty-bearing pharmaceutical and biotechnology licensing transactions from 2015 to 2026.
Coverage includes:
- More than 1,600 royalty-bearing licensing transactions
- Royalty rate benchmarking by development stage, therapeutic area, technology, company and deal type
- Tiered royalties, escalators and royalty ranges where disclosed
- Supporting financial terms including upfront payments, milestones and total deal value
- Analysis of exclusivity, territorial rights and overall transaction structure
- 537 underlying licensing agreements, including royalty clauses and contractual terms
- Royalty rate trends across 2015-2026
- Structured comparable-deal directories for identifying relevant transaction precedents
Access 537 Real Licensing Agreements and Royalty Clauses
Royalty terms can be difficult to research because headline announcements often provide only limited information on the detailed economics of a transaction.
The dataset provides access to 537 underlying licensing agreements, enabling users to move beyond headline deal announcements and examine how royalty and other commercial provisions are actually structured in real transactions.
These agreements can provide insight into areas including:
- Royalty percentages and ranges
- Tiered royalty structures
- Sales thresholds
- Royalty escalation and reduction mechanisms
- Royalty duration
- Territory
- Exclusivity
- Sublicensing provisions
- Milestone structures
- Other financial and commercial terms
For business development, licensing and legal teams, this provides an opportunity to examine actual contract language and transaction mechanics, rather than relying solely on publicly announced headline terms.
Built for Real-World Licensing Decisions and Valuation
The report is designed to support real licensing decisions - from initial valuation and comparable deal analysis through negotiation and internal transaction approval.
- Business development and licensing teams can identify comparable transactions, benchmark proposed terms and prepare evidence for partner negotiations.
- Valuation and finance teams can use real-world transaction evidence to test royalty assumptions in asset valuations, financial models and forecasts.
- Legal and transaction teams can examine how royalty provisions and related commercial terms are structured in actual agreements.
- Executive and investment committees can use comparable transaction evidence to pressure-test assumptions before approving proposed licensing transactions.
- Consultants, advisers and investors can use the intelligence to support valuation, transaction analysis, due diligence and client engagements.
Save Significant Research Time Without Sacrificing Evidence Quality
Reliable royalty rate information is fragmented across press releases, regulatory filings, financial disclosures, investor materials and licensing agreements.
Finding an individual royalty figure may be relatively straightforward. Building a sufficiently large, structured and genuinely comparable group of transactions to support a valuation or negotiation is a very different research task.
The analyst has already consolidated and classified royalty-bearing transactions, financial terms and underlying contracts so users can move directly to identifying and assessing the evidence most relevant to their deal.
This enables teams to spend less time assembling fragmented transaction information and more time interpreting the evidence, testing assumptions and preparing for the commercial decision itself.
Complimentary Tailored Executive Briefing for Qualifying Purchasers
Qualifying purchasers may also receive a complimentary Executive Briefing tailored to their specific technology, product, asset, platform, pipeline or partnering priorities.
Drawing on the analyst's proprietary deal intelligence, the briefing can identify:
- Relevant comparable transactions
- Royalty rate benchmarks
- Comparable deal structures
- Financial benchmarks
- Potential partners and active dealmakers
- Market and transaction trends relevant to the purchaser's objectives
- Practical observations to support valuation, licensing strategy and negotiation planning
The published report provides the market evidence; the tailored briefing helps show how that evidence applies to the purchaser's own commercial situation.
Qualifying purchasers are typically pharmaceutical, biotechnology or other life sciences companies with an identifiable product, technology, asset, platform or partnering objective that can be meaningfully benchmarked against the analyst's deal intelligence.
Table of Contents
Executive Summary
Chapter 1 - Introduction
Chapter 2 - An overview of pharmaceutical and biotechnology royalty rates
Chapter 3 - The royalty clause in pharmaceutical and biotechnology deals
Chapter 4 - Companies actively disclosing royalty rates
Chapter 5 - Royalty rate contract directory
Deal Directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 23andMe
- 2seventy bio
- 3a-diagnostics
- 3B Pharmaceuticals
- 3D Medicines
- 3SBio
- 4D Molecular Therapeutics
- 4SC
- 9 Meters Biopharma
- Aadi Bioscience
- Abbisko Therapeutics
- Abbvie
- AbCellera Biologics
- Abeona Therapeutics
- Abex Pharmaceutica
- ABL Bio
- Ablynx
- ABVC BioPharma
- ABX
- AC Immune
- ACADIA Pharmaceuticals
- Acceleron Pharma
- Accent Therapeutics
- Accord Healthcare
- Accro Bioscience
- Acelrx Pharmaceuticals
- Acer Therapeutics
- Acerus
- Aclaris Therapeutics
- Acorda Therapeutics
- Acrotech Biopharma
- Actinium Pharmaceuticals
- Acuitas Therapeutics
- Acumen Pharmaceuticals
- Acura Pharmaceuticals
- Adamis Pharmaceuticals
- Adaptimmune
- AdaptVac
- ADC Therapeutics
- Adcendo
- ADEL
- Adial Pharmaceuticals
- Adimab
- Aditx Therapeutics
- Adlai Nortye
- Adocia
- Adovate
- Aduro BioTech
- Advaccine Biotechnology
- Advanced Dosage Forms
- Advanz Pharma
- Advaxis
- Aegerion Pharmaceutical
- Aeglea BioTherapeutics
- Aelis Pharma
- Aerami Therapeutics
- Aerie Pharmaceuticals
- Aeromics
- Aerpio Pharmaceuticals
- AEterna Zentaris
- Aevi Genomic Medicine
- Aexon Labs
- Affibody
- Affimed Therapeutics
- AFFiRiS
- AFT Pharmaceuticals
- Agenus Bio
- Agios Pharmaceuticals
- AgNovos Healthcare
- Aguettant
- AiBtl BioPharma
- Aimmune Therapeutics
- AirNexis Therapeutics
- AIT Therapeutics
- Aitia
- Akamis Bio
- Akcea Therapeutics
- Akebia Therapeutics
- Akeso Biopharma
- Alaunos Therapeutics
- Albireo
- Alder Biopharmaceuticals
- Alector
- Alexion Pharmaceuticals
- Alfasigma
- ALK-Abello
- Alkem Laboratories
- Allecra Therapeutics
- Allergan
- Allist Pharma
- Allogene Therapeutics
- Almirall
- Alnylam Pharmaceuticals
- Alora Pharmaceuticals
- Alpha Biopharma
- Alphamab Biopharmaceuticals
- Alphamab Oncology
- Alpine Immune Sciences
- Altamira Pharma
- Alteogen
- Alternavida
- Altesa Biosciences
- Altum Pharmaceuticals
- Alumis
- Aluztra Bio
- Alvogen
- Amag Pharmaceuticals
- Amarantus BioSciences
- Amarin
- Ambrx
- Amgen
- Amherst Pharmaceuticals
- Amicus Therapeutics
- AMMTeK
- Amneal Pharmaceuticals
- Amphista Therapeutics
- Amplyx Pharmaceuticals
- Amryt Pharma
- Amylyx Pharmaceuticals
- AnaptysBio
- AnGes MG
- Angion Biomedica
- AnHeart Therapeutics
- Anima Biotech
- Anivive Lifesciences
- AnnJi Pharmaceutical
- Antares Pharma
- Antengene
- Anteris Bio
- Antibe Therapeutics
- Antigen Express
- Antion Biosciences
- Apellis Pharmaceuticals
- Apic Bio
- Apollo Therapeutics
- ApolloBio
- Applied Therapeutics
- AprilBio
- Aptamer Therapeutics
- Aptose Biosciences
- Aquestive Therapeutics
- Aravive Biologics
- Arbor Biotechnologies
- Arbormentis
- Arbutus
- ARCA Biopharma
- Arcellx
- Arch Pharmalabs
- Arctic Vision
- Arcturus Therapeutics
- Arcus Biosciences
- Arcutis Biotherapeutics
- Ardelyx
- Arena Pharmaceuticals
- argenx
- Ariad Pharmaceuticals
- Aridis Pharmaceuticals
- Arlington Scientific
- ArQule
- Arrakis Therapeutics
- Array Biopharma
- Arrowhead Pharmaceuticals
- ARS Pharmaceuticals
- ARScience Biotherapeutics
- Artios Pharma
- Artiva Biotherapeutics
- Arvinas
- Asahi Kasei
- Ascendis Pharma
- Asceneuron
- Ascentage Pharma
- Ascletis
- Ashvattha Therapeutics
- ASKA Pharmaceuticals
- Aslan Pharma
- Aspire Health Science
- Aspire Pharma
- Assembly Biosciences
- Assistance Publique-Hôpitaux de Paris
- Astellas Pharma
- AstraZeneca
- Astria Therapeutics
- Atara Biotherapeutics
- Athenex
- Athersys
- Atlantic Healthcare
- Atossa Therapeutics
- Atreca
- Audentes Therapeutics
- Augmenta
- AUM Biosciences
- Auransa
- Aurealis Therapeutics
- Aurigene Discovery Technologies
- Aurinia Pharmaceuticals
- Authentic Brands Group
- Autolus
- Avacta
- Avadel Pharmaceuticals
- Avalo Therapeutics
- Avata Biosciences
- Avecho Biotechnology
- Avenue Therapeutics
- AVEO Oncology
- Avero Diagnostics
- Avid Bioservices
- Avidity Biosciences
- Avivagen
- Axovant Gene Therapies
- Axsome Therapeutics
- Aytu BioPharma
- Azaya Therapeutics
- Baker Brothers Investments
- BAKX Therapeutics
- Baliopharm
- Basilea Pharmaceutica
- Bausch Health Companies
- Bavarian Nordic
- Baxalta
- Bayer
- Beam Therapeutics
- BeiGene
- Beijing Defengrei Biotechnology
- Beijing InnoCare Pharma
- Beijing Mabworks Biotech
- Beijing Podconley Pharmaceutical Technology and Development
- Bellerophon Therapeutics
- Bellicum Pharmaceuticals
- Benitec Biopharma
- Benuvia Therapeutics
- BeOne Medicines
- Besins Healthcare
- Beta Bionics
- Betta Pharmaceuticals
- BetterLife Pharma
- Bharat Biotech
- BICO
- Bicycle Therapeutics
- Bio-Rad Laboratories
- Bio-Thera Solutions
- BioArctic AB
- biOasis Technologies
- BioAtla
- Biocodex
- Biocon
- BioCorRx
- BioCryst Pharmaceuticals
- Biocytogen
- BioDelivery Sciences
- Biodexa Pharmaceuticals
- Bioeq IP
- Biogen
- BioGenetics
- Biohaven Pharmaceuticals
- BioHEP Technologies
- BioInvent
- BiolineRX
- Biolojic Design
- BioMarin Pharmaceutical
- Biomerica
- Biond Biologics
- BioNexus Gene Lab
- BioNova Pharmaceuticals
- BioNovion
- BioNTech
- BioNxt Solutions
- Biopas Laboratories
- BiopharmX
- BioPhausia
- Biophytis
- Bioprocess Capital Ventures
- Bioprojet
- Biora Therapeutics
- BioSense Global
- Biosion
- Biosplice
- Biossil
- Biostem US
- BioTheryX
- Bioverativ
- Bixink Therapeutics
- Blackstone
- Blanver
- Bluebird Bio
- Blueprint Medicines
- BlueRock Therapeutics
- BMV Medica
- BNC Korea
- Boehringer Ingelheim
- Bone Therapeutics
- Boryung Pharmaceutical
- Botanix Pharmaceuticals
- Braeburn Pharmaceuticals
- Breathtec BioMedical
- BriaCell Therapeutics
- BriaPro Therapeutics
- Brickell Biotech
- Bridge Biotherapeutics
- BridgeBio Pharma
- BridGene Biosciences
- Brigham and Women's Hospital
- Brii Biosciences
- Bristol-Myers Squibb
- C4 Therapeutics
- Cabaletta Bio
- Calidi Biotherapeutics
- California Institute for Biomedical Research
- Calithera Biosciences
- Calliditas Therapeutics
- CAMP4 Therapeutics
- Camurus
- Can-Fite BioPharma
- CanAm Bioresearch
- CANbridge Pharmaceuticals
- Cancer Prevention Pharmaceuticals
- Candel Therapeutics
- Cann Pharmaceutical Australia
- Cannassure Therapeutics
- CanniMed Therapeutics
- Canntab Therapeutics
- Cannus Partners
- CanProbe
- Cantabria Pharma
- Cantargia
- Cantex Pharmaceuticals
- Capricor Therapeutics
- Capsida Biotherapeutics
- Cara Therapeutics
- Cardiff University
- Caribou Biosciences
- Carna BioSciences
- Carpegen
- CASI Pharmaceuticals
- Cassiopea
- Castle Biosciences
- Castle Creek Biosciences
- Catalyst Pharmaceuticals
- Catholic University Leuven
- CB2 Therapeutics
- CBC Group
- Cedars-Sinai Medical Center
- Celdara Medical
- Celgene
- Cell Cure Neurosciences
- CellAct
- Cellectis
- Cellenkos
- Cellerant Therapeutics
- Cellular Biomedicine
- Cellvera
- Celyad
- Cend Therapeutics
- Centessa Pharmaceuticals
- Centrexion
- Cereal Ingredients
- Cerus
- CGA 369
- cGreen
- Checkpoint Therapeutics
- Chelexa Biosciences
- Chengdu Kanghua Biological Products
- Chi-Med
- Chiesi Farmaceutici
- Chimerix
- China Oncology Focus
- Chinese University of Hong Kong
- Chinook Therapeutics
- Chong Kun Dang
- Chongqing Jingdong Pharmaceutical
- Chugai Pharmaceutical
- Cidara Therapeutics
- Cilag AG
- Cipher Pharmaceuticals
- Cipla
- Circassia
- Citius Pharmaceuticals
- City of Hope
- City Therapeutics
- Clearmind Medicine
- Clearside Biomedical
- Cleave Therapeutics
- Clementia Pharmaceuticals
- Cleveland BioLabs
- Click Therapeutics
- Climb Bio
- Clinigen
- Clovis Oncology
- CMG Pharmaceutical
- CMS Medical
- CNS Pharmaceuticals
- Coave Therapeutics
- Cocrystal Pharma
- Codex DNA
- Codexis
- Codiak BioSciences
- Coeptis Pharmaceuticals
- Coherus Biosciences
- Collegium Pharmaceuticals
- Columbia Care
- Columbia University
- Common Sense
- Compugen
- Conatus Pharmaceuticals
- ConforMIS
- Consilient Health
- Context Therapeutics
- Contineum Therapeutics
- Copernicus Therapeutics
- Corbus Pharmaceuticals
- CorMatrix Cardiovascular
- Cortice Biosciences
- CORXEL Pharmaceuticals
- Cosmo Pharmaceuticals
- Cosmofix
- COUR Pharmaceutical
- Coya Therapeutics
- Crescita Therapeutics
- Crestovo
- CRISPR Therapeutics
- Crossject
- Crosswalk Therapeutics
- CRT Pioneer Fund
- CrystalGenomics
- CS Pharmaceuticals
- CSL
- CSL Behring
- CSPC Pharmaceutical Group
- CStone Pharmaceuticals
- CTI BioPharma
- CTT Pharmaceutical
- Cue Biopharma
- Cullinan Oncology
- Cullinan Therapeutics
- Cumberland Pharmaceuticals
- Cumulus Oncology
- Curadev Pharma
- Curasight
- Cures Within Reach
- Curetis
- CureVac
- Curis
- Curium
- Curon Biopharmaceutical
- Currax Pharmaceuticals
- Cybin
- Cyclerion Therapeutics
- CymaBay Therapeutics
- Cyprium Therapeutics
- Cytodyn
- Cytokinetics
- CytoLynx Therapeutics
- CytomX Therapeutics
- Cytori Therapeutics
- Cytovant Sciences
- CYTOVIA Therapeutics
- CytRx
- D&D Pharmatech
- D. E. Shaw Research
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dare Bioscience
- DAS Therapeutics
- Day One Biopharmaceuticals
- DCx Biotherapeutics
- Debiopharm
- Decibel Therapeutics
- Deciphera Pharmaceuticals
- Deimos Biosciences
- DelSiTech
- Denali Therapeutics
- Department of Health and Human Services
- DepoMed
- Dermavant Sciences
- Dermelix Biotherapeutics
- Dermira
- DeuteRx
- DiaMedica
- Dianomi Therapeutics
- Dianthus Therapeutics
- Dicerna Pharmaceuticals
- Dimerix Biosciences
- Diurnal
- Dong-A ST
- Dr. Falk Pharma
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- Dren Bio
- DRI Capital
- DRI Healthcare
- DualityBio
- Duke University
- Durect
- Dyadic International
- Dynavax Technologies
- EA Pharma
- Eagle Pharmaceuticals
- Earendil Labs
- Easton Pharmaceuticals
- Eberhard Karls University Tubingen
- Eczacibasi Pharmaceuticals
- Egalet
- Eidos Therapeutics
- Eiger BioPharmaceuticals
- EirGen Pharma
- Eirion Therapeutics
- Eisai
- Elanco
- Elektrofi
- Elencee
- Elevar Therapeutics
- Eli Lilly
- Elpiscience
- Emerald Organic Growth
- Emergent BioSolutions
- Emmaus Life Sciences
- Emory University
- Emtora Biosciences
- Enable Injections
- Enalare Therapeutics
- Endo International
- Endo Ventures
- EndoCeutics
- Endocyte
- EndoLogic
- EnGeneIC
- Enochian Biosciences
- Ensho Therapeutics
- Ensoma
- Entera Bio
- Enteris Biopharma
- Entrada Therapeutics
- Enumeral Biomedical
- Enveric Biosciences
- Enzymotec
- EPI Health
- Epitopea
- Epizyme
- EQRx
- Equillium
- Erasca
- Ergomed
- Esperion Therapeutics
- Eterna Therapeutics
- Ethypharm
- Eton Pharmaceuticals
- Euratom
- Eurofarma
- Evecxia
- Evelo Biosciences
- Everest Medicines
- Everest Pharma
- Eversana
- Evoke Pharma
- Evotec
- Evox Therapeutics
- Ewopharma
- Exacis Biotherapeutics
- Exact Sciences
- Exavir Therapeutics
- Exelixis
- Exeltis
- Exicure
- ExpreS2ion Biotechnologies
- Exscientia
- EyeCRO
- Eyenovia
- Eyevance
- F-Star Therapeutics
- F1 Oncology
- Famy Life Sciences
- Fate Therapeutics
- Fennec Pharmaceuticals
- Ferozsons Laboratories
- Ferrer
- Ferring Pharmaceuticals
- Fibrocell Science
- Fidelion Diagnostics
- Filament Health
- First Wave Bio
- Five Prime Therapeutics
- Flexion Therapeutics
- Foghorn Therapeutics
- Forcefield Therapeutics
- Foresee Pharmaceuticals
- FORMA Therapeutics
- Formation Bio
- Formycon
- ForSeeCon Eye Corporation
- Fortify Therapeutics
- Forty Seven
- FORUS Therapeutics
- Fosun Pharmaceutical
- Fox Chase Chemical Diversity Center
- Freeline Therapeutics
- Freenome
- Frequency Therapeutics
- Fresenius Kabi Pharmaceuticals
- Fresh Tracks Therapeutics
- Frontier Biotech
- FSD Pharma
- FUJIFILM Cellular Dynamics
- Fulcrum Therapeutics
- Fusion Pharmaceuticals
- FutureGen Biopharm
- G1 Therapeutics
- Gaelan Medical
- Galapagos
- Galderma
- Galenica
- Galera Therapeutics
- Galmed Pharmaceuticals
- Gamida Cell
- GC Pharma
- GE Healthcare
- GEMMA Biotherapeutics
- GenEdit
- Genelux
- Genentech
- GeneQuantum Healthcare
- GeneQuine Biotherapeutics
- Generate Biomedicines
- Generex Biotechnology
- Generian Pharmaceuticals
- Genevant Sciences
- Genexine
- Genfit
- GenFleet Therapeutics
- Genhouse Bio
- GenKOre
- Genmab
- Genor Biopharma
- Genovis
- Genrix Bio
- Gensci
- GenScript ProBio
- Genzyme
- German Cancer Research Center
- Germfree
- Gicell
- Gilead Sciences
- Gilgamesh Pharmaceuticals
- Glaukos
- Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals S.A.
- Global Blood Therapeutics
- GO Therapeutics
- Goldfinch Bio
- Gossamer Bio
- GPCR Therapeutics
- Gracell Biotechnologies
- Grail
- Gravitas Therapeutics
- Graviton Bioscience
- Gravocore
- Grifols
- Gritstone Bio
- GSK
- GT Biopharma
- Guangzhou Xiangxue Pharmaceutical
- Gurnet Point Capital
- Hai Kang Life
- Haisco Pharmaceutical
- Halo Labs
- Halozyme Therapeutics
- HanAll Pharmaceuticals
- Handa Therapeutics
- Handok Pharmaceuticals
- Hangzhou Chance Pharmaceuticals
- Hangzhou Highlightll Pharmaceutical
- Hangzhou Zhongmei Huadong Pharmaceutical
- HanX Biopharmaceuticals
- Harbour Biomed
- Harmony Biosciences
- Harvard University
- HCW Biologics
- Healios K.K.
- Health Canada
- Health Hope Pharma
- Healthcare Royalty Partners
- Hebrew University of Jerusalem
- Hefei Life Science
- Hefei Tianhui Incubation of Technologies
- Heidelberg Pharma
- HekaBio
- Helmholtz Zentrum Munchen
- Helsinn Therapeutics
- Hemogenyx
- Hemostemix
- HemPup
- Henlius Biotech
- Hepalys Pharma
- Hetero Labs
- HIBio
- HilleVax
- HLS Therapeutics
- Hoffmann La Roche
- Hollister Biosciences
- Hookipa Pharma
- Horizon Therapeutics
- Hoth Therapeutics
- Huadong Medicine
- Humanigen
- Huons
- Hutchmed
- Hyloris Pharmaceuticals
- I-mab
- IASO Biotherapeutics
- Icahn School of Medicine at Mount Sinai
- Ice + Jam
- iCeutica
- Ichnos Glenmark Innovation
- Ichnos Sciences
- IconOVir Bio
- Iconovo
- Icosavax
- IDEAYA Biosciences
- Idera Pharmaceuticals
- Idorsia
- IGM Biosciences
- ImaginAb
- Imbrium Therapeutics
- iMetabolic Biopharma
- Immatics Biotechnologies
- Immedica
- Immugenyx
- Immune System Regulation
- ImmuneCyte Life Sciences
- ImmuneOncia Therapeutics
- ImmuneOnco Biopharmaceuticals
- ImmuNext
- ImmunGene
- Immunic
- ImmunityBio
- ImmunoGen
- Immunome
- Immunomedics
- Immunomic Therapeutics
- ImmunoScape
- Immunovia
- Immutep
- ImmVira
- Imprimis Pharmaceuticals
- Imugene
- In4Derm
- Incannex Healthcare
- Incuron
- Incyte
- InDex Pharmaceuticals
- Indivior
- Inexia
- InfectoPharm
- Infinity Pharmaceuticals
- InflaRx
- Inhibrx
- Initiator Pharma
- Inmagene Biopharmaceuticals
- InMed Pharmaceuticals
- Innate Pharma
- Innocoll
- Innovate Biopharmaceuticals
- Innovation Pharmaceuticals
- Innovative Cellular Therapeutics
- Innovent Biologics
- Innovet
- Innoviva
- Innoviva Specialty Therapeutics
- INO Therapeutics
- Inovio
- Inovio Pharmaceuticals
- Insilico Medicine
- Insitro
- Insmed Inc
- Inspirna
- Instil Bio
- Intact Therapeutics
- Intarcia Therapeutics
- Intas Pharmaceuticals
- IntelGenx
- Intellia Therapeutics
- Intract Pharma
- Intrexon
- iNtRON Biotechnology
- Invekra
- InveniAI
- Invenra
- Inventiva
- Iolyx Therapeutics
- Ion Channel Innovations
- Ionis Pharmaceuticals
- Iovance Biotherapeutics
- IOVaxis Therapeutics
- Ipsen
- IRLAB
- Iroko Pharmaceuticals
- Ironwood Pharmaceuticals
- Isofol Medical
- Isomorphic Labs
- Itrom Pharmaceutical Group
- Ivantis
- Iveric Bio
- iX Biopharma
- Jacobio Pharmaceuticals
- Jacobus Pharmaceutical
- Jadeite Medicines
- Janssen Biotech
- Janssen Pharmaceutica NV
- Janssen Pharmaceuticals
- Japan Tobacco
- Jazz Pharmaceuticals
- JCR Pharmaceuticals
- Ji Xing Pharmaceuticals
- Jiangsu Alphamab
- Jiangsu Aosaikang Pharmaceutical
- Jiangsu Chia Tai Tianqing Pharmaceutical
- Jiangsu Hansoh Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- Jiangsu NHWA Pharmaceutical
- Jinzhou Ahon Pharma
- Johannes Gutenberg University
- John Morley Foods
- Joincare Pharmaceutical
- Jolt Health
- Jounce Therapeutics
- Journey Medical
- Joyo Pharmatech
- JT Pharmaceuticals
- Jubilant Life Sciences
- Jumpcan Pharmaceutical
- Juno Therapeutics
- Junshi Biosciences
- Jupiter Bioventures
- Jupiter Wellness
- Juventas Therapeutics
- Juyou Biotechnology
- JW Pharmaceutical
- Kadmon Pharmaceuticals
- Kainos Medicines
- Kaken Pharmaceutical
- Kalbe Genexine Biologics
- KalVista Pharmaceuticals
- Karuna Therapeutics
- Karveer Meditech
- Karyopharm Therapeutics
- Kashiv BioSciences
- Kastle Therapeutics
- Kazia Therapeutics
- Kelonia Therapeutics
- KemPharm
- Keros Therapeutics
- KeyBioScience
- Keymed Biosciences
- Kezar Life Sciences
- Kiadis Pharma
- Kindred Bio
- Kineta
- Kiniksa Pharmaceuticals
- Kintor
- Kiq
- Kiromic Biopharma
- Kissei Pharmaceutical
- Kite Pharma
- Kitov Pharma
- Klaria
- Klinge Biopharma
- Knight Therapeutics
- Knighton Foods
- Kodiak Sciences
- Kolon Life Science
- Korea Pharma
- Kowa
- Kowa Pharmaceuticals America
- KPM Tech
- Kuhnil Pharmaceuticals
- Kukbo
- Kura Oncology
- KVK-Tech
- Kwang Dong Pharmaceutical
- Kwangdong Pharmaceutical
- Kymera Therapeutics
- Kyn Therapeutics
- Kyowa Hakko Kirin
- Kyverna Therapeutics
- L1 Systems
- La Jolla Pharmaceutical
- Laboratoires Thea
- Laboratories Acbel
- LadRx
- Landos Biopharma
- LaNova Medicines
- Lantheus Holding
- Lantheus Medical Imaging
- Launch Therapeutics
- Lava Therapeutics
- Lee Moffitt Cancer Center
- Lee's Pharmaceutical
- Legend Biotech
- LegoChem Biosciences
- Leiden University
- Leman SKL SA
- LENZ Therapeutics
- LEO Pharma
- Lepu Biopharma
- Les Laboratoires Servier
- Level Brands
- Lexicon Pharmaceuticals
- LG Life Sciences
- LianBio
- Lifestyle Delivery Systems
- Ligand Pharmaceuticals
- Lighthouse Pharmaceuticals
- LimmaTech Biologics
- Lindy Biosciences
- Lineage Cell Therapeutics
- Link Health
- LIPAC Oncology
- Lipidor
- Lipocine
- Lixte Biotechnology
- Lobesity Pharma
- LogicBio Therapeutics
- Lorna Linda University
- Lotus Pharmaceuticals
- Loxo Oncology
- Lubrizol
- Lucideon
- Lundbeck
- Lung Therapeutics
- Lycia Therapeutics
- Lyell Immunopharma
- Lynk Pharmaceuticals
- Lyra Therapeutics
- Lytix Biopharma
- MaaT Pharma
- MabCare Therapeutics
- Mabwell Bioscience
- Macrogenics
- Madrigal Pharmaceuticals
- Magenta Therapeutics
- MagnaPharm Group
- MainPointe
- Mainz University Medical Centre
- Mallinckrodt Pharmaceuticals
- Mammoth Biosciences
- Marathon Pharmaceuticals
- Marina Biotech
- Marinus Pharmaceuticals
- Maruho
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Matrix Biomed
- Mawson Infrastructure
- Mayne Pharma
- Mayo Clinic
- MC2 Therapeutics
- McQuade Center for Strategic Research and Development
- MD Anderson Cancer Center
- Medac
- Medexus Pharmaceuticals
- Mediar Therapeutics
- Medice Arzneimittel Pütter
- Medicines Patent Pool Foundation
- Medicox
- Medicure
- MediGene
- Medigus
- MedImmune
- MedinCell
- Medison Pharma
- Medivir
- MediWound
- Medix
- MedRhythms
- Medshine Discovery
- MEI Pharma
- Meiji Seika
- MeiraGTx
- Melinta Therapeutics
- Melior Pharmaceuticals
- Memo Therapeutics
- Memorial Sloan Kettering Cancer Center
- Menarini
- Mercer University
- Merck and Co
- Merck KGaA
- Merck Sharpe & Dohme
- Mereo BioPharma
- Mersana Therapeutics
- Merus
- Mesoblast
- Metacrine
- Metavant
- Methodist Hospital Houston
- Microbio Shanghai
- MiMedx
- Mimi’s Rock
- MiNA Therapeutics
- MindBio Therapeutics
- Mindset Pharma
- Minghui Pharmaceutical
- MiNK Therapeutics
- Mira Pharmaceuticals
- Miralogx
- Mirati Therapeutics
- Miravo Healthcare
- Mirna Therapeutics
- Miromatrix Medical
- Mirum Pharmaceuticals
- Mithra Pharmaceuticals
- Mitobridge
- Mitsubishi Tanabe Pharma
- Moderna
- ModeX Therapeutics
- Modis Therapeutics
- Molecular Partners
- Moleculin Biotech
- Molipharma
- Mologen
- Molteni Farmaceutici
- Momenta Pharmaceuticals
- Monash University
- Monopar Therapeutics
- Monte Rosa Therapeutics
- Morgan Stanley
- Morningside Ventures
- Morphic Therapeutic
- MorphoSys
- Mount Sinai Health System
- MultiCell Immunotherapeutics
- Multitude Therapeutics
- Mundipharma
- MycoMedica Life Sciences
- Mylan Laboratories
- Mylan Pharmaceuticals
- MyoKardia
- Myovant Sciences
- Nabriva Therapeutics
- Nanjing Leads Biolabs
- Nanobiotix
- NanoCarrier
- NanoVibronix
- NanoViricides
- NantCell
- NantKwest
- Nantong Jinghua Pharmaceutical
- NantWorks
- Nanyang Technological University
- National Cancer Institute
- National Green Biomed
- National Institute of Allergy and Infectious Diseases
- National Resilience
- National University Hospital
- National University of Singapore
- Navidea Biopharmaceuticals
- Nektar Therapeutics
- Neoleukin Therapeutics
- Neomorph
- Neovacs
- Nestle Health Science
- Neuraxpharm
- Neuren Pharmaceuticals
- Neurimmune Therapeutics
- Neurizon Therapeutics
- Neuro Bio
- NeuroBo Pharmaceuticals
- Neurocrine Biosciences
- NeuroRx
- NeuroSense Therapeutics
- NeuroTrauma
- NeuroVive Pharmaceutical
- Nevakar
- NewAmsterdam Pharma
- NewG Lab
- NewLeaf Brands
- Newron Pharmaceuticals
- Newsoara Biopharma
- NextCure
- Nextleaf Solutions
- NGM Biopharmaceuticals
- Nicox
- Nicoya
- Nimble Therapeutics
- Nimbus Therapeutics
- Nippon Shinyaku
- NitricGen
- Nkarta Therapeutics
- NLC Pharma
- NLS Pharmaceutics
- Noile-Immune Biotech
- Nona Biosciences
- Norgine
- North Star Holdings
- NorthStar Medical Radioisotopes
- Northwest Biotherapeutics
- Northwestern University
- Notable Labs
- Notch Therapeutics
- Novan
- Novan Therapeutics
- Novartis
- Novavax
- NoveCite
- Novellus Therapeutics
- Novo Nordisk
- NovoCodex
- Novocure
- NRx Pharmaceuticals
- NT Pharma
- Nuance Pharma
- Nucorion
- Numab
- Nunzi Pharmaceutical
- Nurix Therapeutics
- Nuvation Bio
- Nuvo Research
- Nxera Pharma
- NXTGEN
- Nykode Therapeutics
- Oberland Capital
- ObsEva
- Oceanus Bio
- Ocugen
- Ocular Therapeutics
- Oculus Innovative Sciences
- Ocumension Therapeutics
- Ocuphire Pharma
- Ohio State Innovation Foundation
- OKYO Pharma
- Olema Oncology
- Omega Therapeutics
- Omeros
- OMERS
- OmniAb
- Ona Therapeutics
- OncoArendi Therapeutics
- OncoCyte
- Oncologie
- Oncolytics Biotech
- Onconova Therapeutics
- OncoSec Medical
- OncoX BioPharma
- One Way Liver Genomics (OWL)
- Onegevity
- Oneness Biotech
- ONK Therapeutics
- Ono Pharmaceutical
- Onxeo
- OPKO Health
- Opsis Therapeutics
- Opthea
- OptiBiotix
- Optieum Biotechnologies
- OptiNose
- Opus Genetics
- Oramed Pharmaceuticals
- Orchard Therapeutics
- Orexia Therapeutics
- Orexigen Therapeutics
- Orexo
- Organon
- Organovo
- Orgenesis
- ORIC Pharmaceuticals
- Orion
- OSE Immunotherapeutics
- OSI Pharmaceuticals
- OTR Therapeutics
- Otsuka
- Outpost Medicine
- Ovid Therapeutics
- Oxford BioMedica
- Oxis Biotech
- Oyster Point Pharma
- Paion
- Paladin Labs
- Palatin Technologies
- Palvella Therapeutics
- Pandion Therapeutics
- PANTHERx Specialty Pharmacy
- Par Pharmaceutical
- Paragon Biosciences
- Paratek Pharmaceuticals
- Partner Therapeutics
- Passage Bio
- Patagonia Pharmaceuticals
- PDS Biotechnology
- Pediatrix Therapeutics
- PellePharm
- Pepper Bio
- PeptiDream
- Perception Neuroscience
- Pernix Therapeutics
- Pfenex
- Pfizer
- PharmaCyte Biotech
- PharmaEssentia
- PharmaMar
- Pharmanovia
- Pharmastrip
- PharmaTher
- Pharming Group
- PhaseBio Pharmaceuticals
- Pheon Therapeutics
- Philochem
- Philogen
- Phosphagenics
- Piedmont Pharmaceuticals
- Pieris Pharmaceuticals
- Pierre Fabre
- Pint Pharma
- Plexium
- Plexxikon
- Pliant Therapeutics
- POINT Biopharma
- Polyphor
- PolyPid
- Polyrizon
- Portola Pharmaceuticals
- Poseida Therapeutics
- Poxel
- Praxis Precision Medicines
- Precigen
- Precision BioSciences
- Prelude Therapeutics
- Presage Biosciences
- Pressure BioSciences
- Prevail Therapeutics
- Prilenia Therapeutics
- PRIMA BioMed
- Primevera Therapeutics
- Principia Biopharma
- PRISM BioLab
- Processa Pharmaceuticals
- Profound Medical
- ProGen Co
- Progenics Pharmaceuticals
- Prokaryotics
- Proliant Health and Biologicals
- Promedico
- Prometheus Biosciences
- ProNAi Therapeutics
- ProQR Therapeutics
- Protagonist Therapeutics
- Protalix BioTherapeutics
- ProteoMediX
- Proteostasis Therapeutics
- Proteovant Therapeutics
- ProtoKinetix
- Provectus Biopharmaceuticals
- Provention Bio
- Providence Therapeutics
- Psyence Therapeutics
- PT Etana Biotechnologies
- PTC Therapeutics
- Pulmatrix
- Puma Biotechnology
- Purdue Pharma
- PureTech Health
- Purnovate
- Pyramid Biosciences
- Pyxis Oncology
- QED Therapeutics
- Qilu Pharmaceutical
- Qualigen
- Queensland University of Technology
- Quellis Biosciences
- Quince Therapeutics
- Quoin Pharmaceuticals
- Ra Pharmaceuticals
- Race Oncology
- Radius Health
- Rafael Pharmaceuticals
- Rain Oncology
- Rani Therapeutics
- Rasayana Therapeutics
- Rayner Surgical
- RayzeBio
- Recludix Pharma
- Recordati
- Recursion
- RedHill Biopharma
- Redx Pharma
- Reedy Creek Investments
- Regeneron Pharmaceuticals
- Regenity Biosciences
- Regenxbio
- Regnum
- Regor Therapeutics
- Relay Therapeutics
- Relief Therapeutics
- Relife
- Relmada Therapeutics
- RemeGen
- RenalytixAI
- ReNeuron
- Renovacor
- Repair Biotechnologies
- Repare Therapeutics
- Replicel Life Sciences
- Repligen
- Reprise Biomedical
- Res Nova Bio
- Resarci Therapeutics
- Respira Therapeutics
- Restoration Biologics
- resTORbio
- Resverlogix
- Revance Therapeutics
- ReveraGen BioPharma
- reViral
- Revitope Oncology
- Revive Therapeutics
- Revolution Medicines
- Rexahn Pharmaceuticals
- Rezolute
- Rgene
- Rhinomed
- Rhizen Pharmaceuticals
- Rhythm Pharmaceuticals
- Ribon Therapeutics
- Rigel Pharmaceuticals
- Ripple Therapeutics
- Roche
- Rockefeller University
- Rocket Pharmaceuticals
- RogCon Biosciences
- Roivant Sciences
- Rosetta Genomics
- Roswell Park Cancer Institute
- ROTOP Pharmaka
- Royalty Pharma
- RQ Biotechnology
- RTW Investments
- Rubius Therapeutics
- Ryvu Therapeutics
- SACCO
- Sagard Healthcare Royalty Partners
- Sage Therapeutics
- Salk Institute
- SAMIL Pharmiceuticals
- Sanara MedTech
- SanBio
- Sandoz
- Sangamo Therapeutics
- Saniona
- Sanofi
- Sanofi-Pasteur
- Sanpellegrino Cosmetics
- SanReno Therapeutics
- Santen Pharmaceutical
- Santhera Pharmaceuticals
- Sanuwave Health
- Sapientia Pharmaceuticals
- Sarepta Therapeutics
- Sato Pharmaceutical
- Satsuma Pharmaceuticals
- Sayre Therapeutics
- Scancell
- Scholar Rock
- Schrodinger
- SciBase
- SciClone Pharmaceuticals
- Scintomics
- SciSparc
- Scopus BioPharma
- Scorpion Therapeutics
- Scribe Therapeutics
- Scripps Research Institute
- Scynexis
- Seagen
- Searchlight Pharma
- Seattle Genetics
- Sebela Pharmaceuticals
- Second Genome
- Secura Bio
- Seelos Therapeutics
- Seer
- Sekris Biomedical
- Selecta Biosciences
- SELLAS Life Sciences Group
- SemaThera
- Senior Paradise
- Senju Pharmaceutical
- Sensory Cloud
- Sentynl Therapeutics
- Seqirus
- Seres Therapeutics
- Serina Therapeutics
- Sermonix Pharmaceutical
- Serum Institute of India
- Sesen Bio
- SevenScore Pharmaceuticals
- Shandong Luoxin Pharma
- Shanghai Haohai Biological Technology
- Shanghai Pharmaceuticals Holdings
- Shattuck Labs
- Shenzhen BioScien Pharmaceuticals
- Shenzhen Salubris Pharmaceuticals
- Shield Therapeutics
- Shin Nippon Biomedical Laboratories
- Shionogi
- Sierra Oncology
- Sigilon Therapeutics
- Silence Therapeutics
- Silo Pharma
- Simcere Pharmaceuticals
- Simcere Zaiming
- Singlomics Biopharmaceuticals
- Sino Biopharmaceutical
- SinoMab Bioscience
- Sinopharm
- Sinovant Sciences
- Sio Gene Therapies
- Sirion Biotech
- Sirius Therapeutics
- Sirtex Medical
- Sitryx
- SK Biopharmaceuticals
- Skye Bioscience
- SkyePharma
- SmartCella
- Smith & Nephew
- Sol-Gel
- Solarvest BioEnergy
- Solasia Pharma
- Solid Biosciences
- Sona Nanotech
- Sonnet BioTherapeutics
- Sonoma BioTherapeutics
- Sorrento Therapeutics
- Sosei
- Sosei Heptares
- SOTIO
- Spark Therapeutics
- Specialised Therapeutics
- Spectrum Pharmaceuticals
- Spero Therapeutics
- Spring Bank Pharmaceuticals
- SpringWorks Therapeutics
- Sprint Biosciences
- Spruce Biosciences
- STADA Arzneimittel
- Staidson (Beijing) BioPharmaceuticals
- Stanford University
- Starton Therapeutics
- Stealth BioTherapeutics
- Stemline Therapeutics
- StemSynergy
- Stoke Therapeutics
- Strongbridge Biopharma
- Structure Therapeutics
- Sucampo AG
- SUDA Pharmaceuticals
- Sumitomo Dainippon Pharma
- Sumitomo Pharmaceuticals
- Summit Therapeutics
- Sun Pharmaceutical
- Sunovion Pharmaceuticals
- Sunshine Lake Pharma
- Surface Oncology
- Surrozen
- Sutro Biopharma
- Suzhou Connect Biopharmaceuticals
- Suzhou Sinovent Pharmaceuticals
- Swedish Orphan Biovitrum
- Sydys Corporation
- SymBio Pharmaceuticals
- Synaffix
- Syndax Pharmaceuticals
- Synergy Strips
- Synthon
- Syros Pharmaceuticals
- Systec
- T-Cell Protect Hellas
- Tactical Relief
- Taiba
- TaiGen Biotechnology
- Taiho
- Takeda Pharmaceutical
- Takeda Pharmaceuticals U.S.A
- Talaris Therapeutics
- Talem Therapeutics
- Tango Therapeutics
- Target Group
- Targovax
- Tarsus Pharmaceuticals
- Tarveda Therapeutics
- Tasly Pharmaceuticals
- Tauriga Sciences
- Tavros Therapeutics
- Taysha Gene Therapies
- TearLab
- Technion Research and Development Foundation
- Teijin
- Tela Bio
- Telcon RF Pharmaceuticals
- Telix Pharmaceuticals
- Telomir Pharmaceuticals
- Temple University
- Tenacia Biotechnology
- TeneoBio
- Terns Pharmaceuticals
- TerSera Therapeutics
- Terumo
- Tesaro
- Tessera Therapeutics
- Tetra Bio-Pharma
- TetraLogic Pharmaceuticals
- Tetraphase Pharmaceuticals
- Teva Pharmaceutical Industries
- TFF Pharmaceuticals
- TG Therapeutics
- Tharimmune
- The Medicines Company
- The Regents of the University of California
- Therakine
- Theramex
- Theranexus
- Therapeutic Solutions International
- TherapeuticsMD
- Therapharm
- Therapyx
- Theratechnologies
- Theravance
- Theravance Biopharma
- Theriva Biologics
- Theseus Pharmaceuticals
- Thorne Research
- TiGenix
- Tilray
- Titan Pharmaceuticals
- TiumBio
- Tizona Therapeutics
- TLC BioSciences
- Todos Medical
- Tonghua Dongbao Pharma
- TONIX Pharmaceuticals
- Torch Biosciences
- Torii Pharmaceutical
- TRACON Pharmaceuticals
- Transcenta
- Transgene
- Transition Bio
- Translate Bio
- Travere Therapeutics
- TreeFrog Therapeutics
- Trek Therapeutics
- Trevena
- TriSalus Life Sciences
- TScan Therapeutics
- Tubulis
- Tufts Medical Center
- Tufts University
- Turing Pharmaceuticals
- Turning Point Therapeutics
- Turnstone Biologics
- Twist Bioscience
- Tyme Technologies
- Ubix Therapeutics
- Ultragenyx Pharmaceuticals
- Undisclosed Company
- Union Springs Pharmaceuticals
- UNION Therapeutics
- UniQure
- United Therapeutics
- Universal Cells
- University College Dublin
- University of Alberta
- University of Arizona
- University of Basel
- University of California San Francisco
- University of Chicago
- University of Connecticut
- University of Geneva
- University of Heidelberg
- University of Louisville
- University of Massachusetts Medical School
- University of Miami
- University of Missouri
- University of North Carolina
- University of Pennsylvania
- University of Southampton
- University of Texas
- University of Tubingen
- University of Washington
- Unnatural Products
- Uppsalagruppen Medical
- UroGen Pharma
- Urovant Sciences
- Vaccibody
- Vaccinex
- Vactech
- Valeant Pharmaceuticals
- Valneva
- Vanda Pharmaceuticals
- Vasomune Therapeutics
- Vaxart
- VaxEquity
- VAYA Pharma
- VBI Vaccines
- VBL Therapeutics
- Vectura
- Vera Therapeutics
- Verastem
- Veraxa Biotech
- Vericel
- VerImmune
- Verity Pharmaceuticals
- Verrica Pharmaceuticals
- Vertex Pharmaceuticals
- Verve Therapeutics
- Viatris
- VIB
- Vida Concepts
- Vifor Pharma
- Vifor-Fresenius Medical Care Renal Pharma
- ViiV Healthcare
- Vincera Pharma
- Vir Biotechnology
- Viridian Therapeutics
- Vivelix Pharmaceuticals
- Vividion Therapeutics
- Vivus
- Voronoi
- Voyager Therapeutics
- vTv Therapeutics
- Vyera Pharmaceuticals
- Vyluma
- VYNE Therapeutics
- Warp Drive Bio
- WAVE Life Sciences
- Wellcome Trust
- Werewolf Therapeutics
- Whitehead Institute
- Wigen Biomedicine
- Wilex
- Windtree Therapeutics
- Winhealth Pharma Group
- World Class Extractions
- WPD Pharmaceuticals
- WUGEN
- WuXi Biologics
- WY Biotech
- X4 Pharmaceuticals
- Xbiome
- Xbrane Biopharma
- Xencor
- Xenetic Biosciences
- Xenon Pharmaceuticals
- XERIS Pharmaceuticals
- Xilio Therapeutics
- Xlife Sciences
- Xoma
- XPhyto Therapeutics
- Xspray Pharma
- Xuanzhu Biopharma
- XWPharma
- XyloCor Therapeutics
- Xynomic Pharmaceuticals
- Xyphos Biosciences
- Y-Biologics
- Y-mAbs Therapeutics
- Yakult Honsha
- Yale University
- Yarrow Bioscience
- Yissum Research Development
- Yuhan Corporation
- Yungjin Pharmaceutical
- ZAI Laboratory
- Zealand Pharma
- Zenas BioPharma
- Zenith Epigenetics
- Zentalis Pharmaceuticals
- Zenyaku Kogyo
- Ziopharm Oncology
- Zogenix
- Zydus Cadila
- Zydus Lifesciences
- Zylo Therapeutics
- Zymeworks
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
